ArticleJACC. Case reports2025
Step Forward in Rheumatic Valve Disease: Simultaneous PTMC and TAVI as a Viable Treatment Strategy.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRheumatic heart disease remains prevalent in low-income countries, often leading to combined severe mitral stenosis (MS) and aortic stenosis (AS). Although percutaneous transmitral commissurotomy (PTMC) is the standard treatment for severe MS with suitable anatomy, rheumatic AS is typically excluded from major transcatheter aortic valve implantation (TAVI) trials because of its noncalcific nature. CASE SUMMARY: We present a 72-year-old woman with severe rheumatic AS and MS who underwent simultaneous PTMC and TAVI. PTMC was performed via the right femoral vein using a 25-mm Accura balloon, followed by TAVI with a self-expanding Evolut-R valve, optimizing hemodynamics for her small aortic annulus. TAKE-HOME MESSAGES: Simultaneous PTMC and TAVI can be a safe and effective alternative to surgery in selected patients, offering a less invasive option for managing combined rheumatic valve disease. This case demonstrates its feasibility; however, further studies are needed to assess long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.